))
Freaks, Fund III, and the Future of Biotech: How Alex Fair’s MedStartr is Disrupting VC with a 44% IRR
Manage episode 488412009 series 3147351
Content provided by Adi. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Adi or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
What happens when a retired-at-38 scientist turns a crowdfunding platform into one of the most predictive biotech VC machines on the planet? In this high-voltage episode of 9x90™, Adi Soozin interviews Alex Fair, founder of MedStarter, a medtech and biotech fund redefining early-stage investing. With a 44% IRR, MedStarter’s data-driven approach—built on founder psychometrics, expert networks, and founder grit—has funded companies that now move billions and influence healthcare policy.Alex reveals the secrets behind Fund III, their $40M accelerator-backed investment vehicle designed to identify 130 future game-changers before they hit mainstream. You’ll also get a rare look into the elite salons where billionaires, policy-makers, and innovation freaks collaborate, and how “Dinner with the Winners” is helping surface the next great unicorns.Whether you're an LP looking for alpha, a founder with something to prove, or a connector seeking the next wave of disruptors—this is the episode you don’t want to miss.👥 Learn more or connect at medstarter.vc or the upcoming medstarter.capital📧 Contact Alex Fair (with that famously missing ‘e’) for access or deal flow opportunities.
42 episodes
Share
